CELENTYX LIMITED

B15 2SQ (West Midlands)

Start Date

End Date Funded Value Relevance

CSV

25 50 100

£206,812

Jan 21 - Jun 22

Development of a SARS-CoV-2 spike protein binding assay using human epithelial cells for COVID-19 therapy discovery and development

Innovate UK award to CELENTYX LIMITED and Omar Qureshi

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}